[Summary] Protecting life, caring for health
Shanghai Modern Pharmaceutical Co., Ltd. was jointly initiated by Shanghai Institute of Pharmaceutical Industry as the main sponsor, together with five enterprises including the National Pharmaceutical Formulation Engineering Research Center and Shanghai Ruijin Hospital Guangci Medical High-tech Company, and is a high-tech pharmaceutical enterprise aiming at listing.
The company was recognized as a Shanghai High-tech Enterprise in 1997 and has maintained this status since then. All products and dosage forms have passed the GMP certification of the National Medical Products Administration. On June 16, 2004, the A shares of Shanghai Modern Pharmaceutical Co., Ltd. were successfully listed on the Shanghai Stock Exchange with the security code 600420 and the abbreviation 'Modern Pharmaceutical'. Through the capital market, the company achieved an optimal combination of industrial operation and capital operation, greatly forging and cultivating its core competitiveness, and strengthening its confidence in pursuing a path of technological industrialization.
Many of the company's products have been included in national key scientific research projects such as the 'Ninth Five-Year Plan', the Torch Program, Shanghai high-tech achievement transformation projects, and the Shanghai Torch Program, and have repeatedly won awards such as the National Key New Product Award, Shanghai Scientific and Technological Achievement Award, Shanghai Excellent New Product Award, Shanghai Famous Brand Product, and Shanghai Pharmaceutical Industry Famous and Quality Product. Main products include Azithromycin Tablets, Nifedipine Controlled-release Tablets, Cefalexin Sustained-release Capsules, Cefaclor Sustained-release Capsules, Enalapril Maleate Tablets, Dextromethorphan Sustained-release Suspension, and bulk drugs such as Azithromycin, Zidovudine, Drospirenone, and Lipoic Acid, which have high market share and popularity, and sell well in overseas markets.
The strategic goal set by Shanghai Institute of Pharmaceutical Industry Group is to become a world-class high-tech pharmaceutical enterprise group. As the base for industrialization of independent scientific research achievements within the group, Modern Pharmaceutical has determined its own strategic goal, that is, to form a cooperative process connecting upstream and downstream with the group's scientific research innovation system, and to take advantage of the national 'Eleventh Five-Year Plan' special projects including the 'Shanghai Modern Pharmaceutical Drug Integration Innovation Technology Platform' and the 'Establishment of New Drug Formulations and Process Technology Platforms with Process Control' as opportunities to further enhance the capability of transforming independent scientific research achievements into industrialization, forming Modern Pharmaceutical's unique core competitiveness.
What does Shanghai Modern Pharmaceutical Co., Ltd. require? Who is Sinopharm Modern hiring? Sinopharm Modern recruitment: 财务/审计/统计类占比最多占42.4%，其次是质量管理类占30.3%. What education can get in at Sinopharm Modern? 硕士占比最多占97%，其次是本科占3%. High education required at Sinopharm Modern? 硕士占97%. Work experience required at Sinopharm Modern? 3-5年占比最多占33.3%，其次是不限占27.3%. Where are the job locations at Sinopharm Modern? 上海占比最多占87.9%，其次是北京占6.1%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
